CTRI/2018/05/014067进行中（未招募）未知
Randomized Open labeled clinical study to evaluate efficacy,tolerability and safety of Dhoomapana therapy in patients of Lung Cancer.
Rasayani Cancer Clinics Pune0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patient diagnosed with Lung cancer or Lung metastasis.
- •2. Taking Ayurvedic treatment consisting of Dhoomapana
- •3. Willing to undergo treatment with Dhoomapana
排除标准
- •Patients who was suffering from any concomitant illness or taking any concomitant medication which in the opinion of investigator would have confounded with outcome efficacy variables.
- •Patient who were receiving Opoid analgesics.
- •Patient who were receiving other CAM modalities
研究者
相似试验
招募中
不适用
Dhoomapana therapy for cancers.CTRI/2018/04/012964Rasayu Cancer Clinic Pune
尚未招募
2 期
A Clinical study to evaluate the efficacy and safety of Quista-DN health drink in diabetic individualsCTRI/2019/07/020179The Himalaya Drug Company
招募中
3 期
A clinical trial to study the effect of Shunthyadam Vati to prevent heart disease.CTRI/2021/01/030275Dr Abhijit Dinkarrao Shekhar
已完成
2 期
A clinical study to see the effects and safety of PNB-001 in patients with moderate COVID-19 infectioCTRI/2020/10/028423PNB Vesper Life Science Pvt Ltd40
进行中（未招募）
2 期
Management of Ankylosing Spondylitis through AyurvedaCTRI/2019/02/017768ational Institute of Ayurveda